Vitamin D in NAFLD, Diabetes, and Depression: A Mechanistic Link

Background

Non-Alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes Mellitus (T2DM), and depression are interlinked chronic conditions that share common pathophysiological mechanisms such as insulin resistance, chronic inflammation, and oxidative stress. Emerging evidence suggests that Vitamin D deficiency may represent a common underlying factor that contributes to the development and progression of these conditions.

Objectives

This review aims to examine the multifaceted role of Vitamin D in the pathogenesis and clinical progression of NAFLD and T2DM, particularly in the presence of comorbid depression.

Materials and Methods

A comprehensive literature review was conducted using peer-reviewed studies, meta-analyses, and clinical trials published in databases such as PubMed, Scopus, and Google Scholar. Evidence was critically analyzed to identify common biological pathways and therapeutic implications.

Results

Vitamin D influences insulin sensitivity, β-cell function, lipid metabolism, immune modulation, and neuroendocrine regulation. Its deficiency has been associated with worse glycemic control, hepatic steatosis, and depressive symptoms. While interventional studies report modest improvements in insulin resistance and inflammatory markers, findings remain inconclusive regarding long-term hepatic or psychiatric outcomes. Depression, through HPA axis dysfunction and lifestyle factors, further exacerbates metabolic dysregulation and Vitamin D deficiency.

Conclusion

Vitamin D deficiency is a shared modifiable risk factor in NAFLD, T2DM, and depression. A multifactorial approach that combines Vitamin D supplementation with mental health interventions and lifestyle modifications holds promise in improving outcomes. Personalized treatment strategies and further research are warranted to clarify the long-term benefits of Vitamin D in this triad of chronic diseases.